Cargando…
National Research Institute of Tuberculosis and Lung Disease (NRITLD) Protocol for the Treatment of Patients with COVID-19
More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations worldwide have tried to provide integrated treatment guidelines to control coronavirus disease 2019 (COVID-19) at different levels. Ho...
Autores principales: | Mirenayat, Maryam Sadat, Abedini, Atefeh, Kiani, Arda, Eslaminejad, Alireza, Adimi naghan, Parisa, Malekmohammad, Majid, Heshmatnia, Jalal, Nadji, Seyed Alireza, Idani, Esmaeil, Zahiri, Reyhaneh, Lookzadeh, Somayeh, Sheikhzade, Hakimeh, Dastan, Farzaneh, Porabdollah Toutkaboni, Mihan, Rezaei, Mitra Sadat, Askari, Elham, Tabarsi, Payam, Marjani, Majid, Moniri, Afshin, Hashemian, Seyed Mohammad Reza, Farzanegan, Behrooz, Abtahian, Zahra, Yassari, Fatemeh, Mansouri, Nazanin, Mansouri, Davood, Vasheghani, Maryam, Mansourafshar, Babak, Mokhber Dezfoli, Mojtaba, Soleimani, Salman, Seifi, Sharareh, Naghashzadeh, Farah, Fakharian, Atefeh, Varahram, Mohammad, Jamaati, Hamidreza, Zali, Alireza, Velayati, Ali Akbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brieflands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191225/ https://www.ncbi.nlm.nih.gov/pubmed/35765502 http://dx.doi.org/10.5812/ijpr.123947 |
Ejemplares similares
-
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals
por: Marjani, Majid, et al.
Publicado: (2020) -
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran
por: Baghaei, Parvaneh, et al.
Publicado: (2020) -
Uncommon Complications of Lung Transplantation in a Referral Center
por: Mirenayat, Maryam Sadat, et al.
Publicado: (2022) -
Combination therapy of IFNβ1 with lopinavir–ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients
por: Baghaei, Parvaneh, et al.
Publicado: (2021) -
Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial
por: Hafizi, Maryam, et al.
Publicado: (2023)